Benzo[b]thiophen-2-ylmethanamine

Catalog No.: 
ACQRCY049
CAS No.: 
6314-43-8
Molecular Formula: 
C9H9NS
Molecular Weight: 
163.24
Benzo[b]thiophen-2-ylmethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$57.00In stockIn stock
5g96%$255.00In stockIn stock
25g96%$1186.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzo[b]thiophen-2-ylmethanamine
IUPAC Namebenzo[b]thiophen-2-ylmethanamine
MDL No.MFCD03306018
Molecular FormulaC9H9NS
Molecular Weight163.24
SMILESNCC1=CC2=CC=CC=C2S1
InChI KeyWKYFWFHTABURGB-UHFFFAOYSA-N
Synonym2-(Aminomethyl)benzothiophene | AKOS011999849 | Oprea1_679404 | STK064350 | SY034711 | 1-benzothiophen-2-ylmethylamine, AldrichCPR | EN300-55374 | SCHEMBL240588 | NSC40287 | NSC-40287 | A24376 | benzo[b]thiophen-2-ylmethanamine | AM20090174 | Benzo(b)thio
CAS No.6314-43-8
PubChem CID237074

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H314
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACQRCY049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACYADQ509 route compound structure diagram
    ACYADQ5093541-37-5In Stock
  4. Then
  5. ACQRCY049 route product structure diagram
    ACQRCY0496314-43-8In Stock
Inquiry

2. ACQRCY049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLNSM504 route compound structure diagram
    ACLNSM50455219-11-9In Stock
  2. Then
  3. ACQRCY049 route product structure diagram
    ACQRCY0496314-43-8In Stock
Inquiry

3. ACQRCY049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQRCY049 route product structure diagram
    ACQRCY0496314-43-8In Stock
Inquiry

Comments (0)